Close

DepoMed, Inc. (DEPO) Tops Q4 EPS by 4c

March 8, 2012 4:11 PM EST
DepoMed, Inc. (NASDAQ: DEPO) reported Q4 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $10.88 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings